Azar Leads HHS as New Secretary

  • By
  • In CMS
  • January 25, 2018
  • Comments Off on Azar Leads HHS as New Secretary
Azar Leads HHS as New Secretary

Former drug industry executive, Alex Azar, was confirmed by congress by bipartisan vote to be the new secretary of the U.S. Department of Health & Human Services (HHS). The former president of the Big Pharma company Eli Lilly & Co., “will now be in charge of buying more medications than anyone in the world,” according to NPR News. The good news is Azar says drug prices are too high and told members of the Senate Finance Committee they would be a priority.
As for Azar’s views on the Affordable Care Act, according to Healthcare Dive, “Azar has frequently criticized the ACA and would be unlikely to oppose more attempts to repeal or roll it back. He did however tell senators he would implement the law so long as it remains on the books.”
Azar replaces Tom Price, who resigned from HHS in September 2017, and Eric D. Hargan, who was sworn into office as deputy secretary on Oct. 6, 2017 and appointed as acting secretary.
 Alex Azar, Photo credit Wikimedia by Wwsgconnect – Own work, CC BY-SA 4.0

Michelle Dick
Follow me

About Has 257 Posts

Michelle A. Dick, BS, is a freelance content specialist, providing writing, editorial expertise, and graphic imagery to clients. Prior to becoming a free agent, she was an executive editor for AAPC, editor-in-chief at Eli Research, and editor at Element K Journals. After earning a Bachelor of Science from the State University of New York at Buffalo State, Dick entered the publishing industry as a graphic artist, ad coordinator, and web designer for White Directory Publishers, Inc.

Comments are closed.